サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1280717

マイクロバイオームシーケンスサービスの世界市場：サービス別 (サンプル調製、シーケンス・ライブラリー調製)・種類別 (アンプリコンシーケンス、全ゲノムシーケンス)・技術別 (SBS、ナノボアシーケンス)・エンドユーザー別の将来予測 (2028年まで)

Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 193 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
マイクロバイオームシーケンスサービスの世界市場：サービス別 (サンプル調製、シーケンス・ライブラリー調製)・種類別 (アンプリコンシーケンス、全ゲノムシーケンス)・技術別 (SBS、ナノボアシーケンス)・エンドユーザー別の将来予測 (2028年まで)
出版日: 2023年05月17日
発行: MarketsandMarkets
ページ情報: 英文 193 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のマイクロバイオームシーケンスサービスの市場規模は、2023年の2億8,400万米ドルから、2028年には5億5,500万米ドルへと、14.3%のCAGRで成長すると予測されています。

治療薬開発におけるマイクロバイオームシーケンスの用途の拡大は、この市場で活動する企業にとって重要な機会となっています。マイクロバイオームシーケンスは、研究以外の用途も拡大しており、皮膚マイクロバイオームの研究や口腔マイクロバイオームシーケンスなど、治療薬開発に活用されることが増えています。これらの用途は、健康と病気における微生物叢の役割の理解を進め、皮膚の健康と口腔の健康を改善するための標的介入の開発に情報を提供する可能性を持っています。

"サービス別では、シーケンス・ライブラリー調製が予測期間中に最も高い成長率で成長する"

マイクロバイオームシーケンス・ライブラリー調製では、16S rRNAシーケンス、ショットガンメタゲノミクス、qPCR検査、短鎖脂肪酸 (SCFA) 分析など、さまざまなアプローチが採用されています。16S rRNAシーケンスの需要が高いことが、このセグメントの成長を後押しすると予想されます。

"技術別では、2022年にSBS (合成によるシーケンス) セグメントが45%と最大シェアを占める"

SBS技術は、4つの蛍光標識ヌクレオチドを使用して、フローセル表面上の数百万個のクラスターを並行して配列します。

"地域別では、アジア太平洋が予測期間中に最も高いCAGRで成長する"

アジア太平洋地域では、健康と病気におけるマイクロバイオームの重要性に対する認識の高まり、個別化医療に対する需要の高まり、シーケンス技術の進歩などにより、マイクロバイオームシーケンスサービス市場が最も急速に成長すると予想されます。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 技術分析
  • 顧客のビジネスに影響を与える動向と混乱
  • バリューチェーン分析
  • エコシステム・市場マップ
  • ポーターのファイブフォース分析
  • 規制分析
  • 価格分析
  • 主な会議とイベント (2023年～2024年)
  • 主要な利害関係者と購入基準

第6章 マイクロバイオームシーケンスサービス市場：種類別

  • イントロダクション
  • サンプル調製
  • シーケンス・ライブラリー調製
  • データ分析

第7章 マイクロバイオームシーケンスサービス市場：種類別

  • イントロダクション
  • アンプリコンシーケンシング
  • 全ゲノムシーケンシング
  • ショットガンシーケンス
  • その他の種類

第8章 マイクロバイオームシーケンスサービス市場：技術別

  • イントロダクション
  • SBS (合成によるシーケンシング)
  • SBL (ライゲーションによるシーケンシング)
  • ナノポアシークエンシング
  • その他の技術

第9章 マイクロバイオームシーケンスサービス市場：エンドユーザー別

  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • その他のエンドユーザー

第10章 マイクロバイオームシーケンスサービス市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 主要企業が採用した戦略
  • 市場シェア分析
  • 上位企業の収益シェア分析
  • 企業評価クアドラント
  • 競合シナリオ

第12章 企業プロファイル

  • 主要企業
    • CHARLES RIVER LABORATORIES
    • EUROFINS SCIENTIFIC
    • BGI GROUP
    • COSMOSID
    • MICROBA
    • QIAGEN N.V.
    • MICROBIOME INSIGHTS
    • BASECLEAR
    • CD GENOMICS
    • ZYMO RESEARCH CORPORATION
    • ORASURE TECHNOLOGIES
    • MR DNA
    • EREMID GENOMIC SERVICES
    • CLINICAL-MICROBIOMICS A/S
    • NOVOGENE CO., LTD.
  • その他の企業
    • EZBIOME
    • BOSTER BIOLOGICAL TECHNOLOGY
    • ZIFO
    • OMICS2VIEW.CONSULTING GBR
    • MACROGEN, INC.

第13章 付録

目次
Product Code: BT 5306

The microbiome sequencing services market is projected to grow from USD 284 million in 2023 to USD 555 million by 2028 at a CAGR of 14.3%. Expanding applications of microbiome sequencing in therapeutics development serves as a key opportunity for the players operating in this market. Microbiome sequencing is expanding its applications beyond research and is increasingly being utilized in therapeutics development, including the study of the skin microbiome and oral microbiome sequencing. These applications have the potential to advance the understanding of the role of microbiota in health and disease and inform the development of targeted interventions for improving skin health and oral health.

"Sequencing and library preparation segment to witness the highest growth during the forecast period."

Based on service, the microbiome sequencing services market is segmented into sample preparation services, sequencing and library preparation services, and data analysis services. Different approaches are employed in microbiome sequencing and library preparation, including 16S rRNA sequencing, shotgun metagenomics, qPCR testing, and short-chain fatty acids (SCFA) analysis. High demand for 16S rRNA sequencing is expected to boost the growth of this segment.

"The sequencing by synthesis (SBS) segment accounted for the largest share of 45% of the global microbiome sequencing services market in 2022."

Based on technology, the global microbiome sequencing services market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, and other technologies. The SBS technology uses four fluorescently labeled nucleotides to sequence millions of clusters on the flow cell surface in parallel .The SBS technology has a wide customer base owing to its well-established precision in sequencing as well as its broad application base.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

The microbiome sequencing services market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The Asia Pacific region is expected to be the fastest-growing market for microbiome sequencing services due to the increasing awareness of the importance of the microbiome in health and disease, rising demand for personalized medicine, and advancements in sequencing technologies.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Respondent: Supply Side (70%) , Demand side (30%)
  • By Designation: Manager-level (45%), CXO and Director-level (35%), and Executives (25%)
  • By Region: North America (20%), Europe (10%), AsiaPacific (55%), Latin America(10% ) and Middle EastAfrica(5%)

List of Companies Profiled in the Report

  • Charles River Laboratories (US)
  • Eurofins Scientific (France)
  • BGI (China)
  • CosmosID (US)
  • Microba (Australia)
  • QIAGEN (Germany)
  • Microbiome Insights (Canada)
  • BaseClear (Netherlands)
  • CD Genomics (US)
  • Zymo Research (US)
  • OraSure Technologies (US)
  • MR DNA (US)
  • Eremid Genomic Services (US)
  • Clinical-Microbiomics A/S (Denmark)
  • Novogene Co., Ltd. (China)
  • EzBiome (US)
  • Boster Biological Technology (US)
  • Zifo (India)
  • omics2view.consulting GbR (Germany)
  • Macrogen, Inc. (South Korea)

Research Coverage

This report studies the microbiome sequencing services market based on service, type, technology, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total microbiome sequencing services market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing demand for metagenomic sequencing, growing focus on human microbiome therapeutics development, and high cost of advanced infrastructure for sequencing), restraints (dearth of skilled personnel), opportunities (Expanding applications of microbiome sequencing in therapeutics development), and challenges (Issues related to sample preparation/isolation of microbes for sequencing) influencing the growth of microbiome sequencing services market.
  • Service Development/Innovation: Detailed insights on newly launched services, and technological assessment of the microbiome sequencing services market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the microbiome sequencing services market across varied regions.
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the microbiome sequencing services market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Charles River Laboratories International, Inc. (US), Eurofins Scientific (France), BGI (China) among others in the microbiome sequencing services market. The report also helps stakeholders understand the pulse of microbiome sequencing services market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 MICROBIOME SEQUENCING SERVICES MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
    • FIGURE 5 ILLUSTRATIVE EXAMPLE OF COMPANY REVENUE ANALYSIS, 2022
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 7 MICROBIOME SEQUENCING SERVICES MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
    • FIGURE 8 MICROBIOME SEQUENCING SERVICES MARKET: GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 IMPACT OF RECESSION ON MICROBIOME SEQUENCING SERVICES MARKET
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 10 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICROBIOME SEQUENCING SERVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 MICROBIOME SEQUENCING SERVICES MARKET OVERVIEW
    • FIGURE 15 GROWING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE MARKET
  • 4.2 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE AND COUNTRY (2023)
    • FIGURE 16 SEQUENCING AND LIBRARY PREPARATION SERVICES TO ACCOUNT FOR LARGEST SHARE OF NORTH AMERICAN MICROBIOME SEQUENCING SERVICES MARKET IN 2023
  • 4.3 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 SHOTGUN SEQUENCING SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 MICROBIOME SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 MICROBIOME SEQUENCING SERVICES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for metagenomic sequencing
      • 5.2.1.2 Growing focus on human microbiome therapeutics development
    • FIGURE 19 ROLE OF MICROBIOME SEQUENCING IN THERAPEUTICS DEVELOPMENT
      • 5.2.1.3 High cost of advanced infrastructure for sequencing
    • TABLE 5 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Dearth of skilled personnel
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Expanding applications of microbiome sequencing in therapeutics development
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Issues related to sample preparation/isolation of microbes for sequencing
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MICROBIOME SEQUENCING SERVICE PROVIDERS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 21 VALUE CHAIN ANALYSIS OF MICROBIOME SEQUENCING SERVICES MARKET
  • 5.6 ECOSYSTEM MARKET MAP
    • FIGURE 22 ECOSYSTEM OF MICROBIOME SEQUENCING SERVICES MARKET
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 6 MICROBIOME SEQUENCING SERVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 NORTH AMERICA
      • 5.8.1.1 US
    • TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.8.1.2 Canada
    • 5.8.2 EUROPE
    • 5.8.3 ASIA PACIFIC
      • 5.8.3.1 China
    • TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.8.3.2 Japan
      • 5.8.3.3 India
    • 5.8.4 LATIN AMERICA
    • 5.8.5 MIDDLE EAST
    • 5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS: GENOMICS, MICROBIOME RESEARCH, AND METAGENOMICS
  • 5.9 PRICING ANALYSIS
    • TABLE 11 AVERAGE SELLING PRICE, BY SERVICE AND TYPE
    • 5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS
  • 5.10 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 12 MICROBIOME SEQUENCING/METAGENOMIC SEQUENCING/NGS CONFERENCES, 2023-2024
  • 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SEQUENCING SERVICES
    • FIGURE 24 CRITERIA FOR OUTSOURCING SEQUENCING SERVICES

6 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE

  • 6.1 INTRODUCTION
    • TABLE 13 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • 6.2 SAMPLE PREPARATION
    • 6.2.1 NEED FOR SPECIFIC SAMPLE PREPARATION PROTOCOLS BASED ON SAMPLE TYPE TO DRIVE GROWTH
    • TABLE 14 MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SEQUENCING AND LIBRARY PREPARATION
    • 6.3.1 SEQUENCING AND LIBRARY PREPARATION SERVICES TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 19 MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 20 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 22 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 DATA ANALYSIS
    • 6.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE GROWTH
    • TABLE 24 MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 25 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)

7 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 29 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 7.2 AMPLICON SEQUENCING
    • 7.2.1 HIGH ACCURACY OF 16S AMPLICON SEQUENCING TO DRIVE ADOPTION
    • TABLE 30 AMPLICON SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 31 NORTH AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 EUROPE: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 ASIA PACIFIC: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 LATIN AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 WHOLE-GENOME SEQUENCING
    • 7.3.1 ACCURATE REFERENCE GENOMES GENERATED FOR MICROBIAL IDENTIFICATION TO BOOST MARKET
    • TABLE 35 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 36 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 SHOTGUN SEQUENCING
    • 7.4.1 ADVANCEMENTS IN DATA ANALYSIS SOLUTIONS TO SUPPORT ADOPTION
    • TABLE 40 SHOTGUN SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 LATIN AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 OTHER TYPES
    • TABLE 45 OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 EUROPE: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 ASIA PACIFIC: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 LATIN AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 50 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 8.2 SEQUENCING BY SYNTHESIS (SBS)
    • 8.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME
    • TABLE 51 MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 SEQUENCING BY LIGATION (SBL)
    • 8.3.1 INCREASING DEMAND FOR SBL IN FOOD MICROBIOME RESEARCH TO BOOST GROWTH
    • TABLE 56 MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 NANOPORE SEQUENCING
    • 8.4.1 ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES
    • TABLE 61 MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OTHER TECHNOLOGIES
    • TABLE 66 MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 67 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

9 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 71 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 9.2.1 ROBUST FUNDING FOR MICROBIOME-BASED THERAPEUTICS TO DRIVE MARKET
    • TABLE 72 MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 ACADEMIC AND RESEARCH INSTITUTES
    • 9.3.1 EXPANDING APPLICATIONS OF MICROBIOME RESEARCH TO DRIVE GROWTH
    • TABLE 77 MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 OTHER END USERS
    • TABLE 82 MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 25 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
    • TABLE 87 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT
    • TABLE 88 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 90 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 92 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Increasing awareness of microbiome research to drive growth
    • TABLE 93 US: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 94 US: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 US: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 96 US: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing prevalence of chronic diseases to boost microbiome research
    • TABLE 97 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 98 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 100 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: IMPACT OF RECESSION
  • 10.3 EUROPE
    • TABLE 101 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 103 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 105 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Rapidly increasing government funding to support growth
    • TABLE 106 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 107 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 108 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 109 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Significant government investments in genomics research to propel growth
    • TABLE 110 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 111 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 112 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 113 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing number of microbiome sequencing startups to propel growth
    • TABLE 114 HUMAN MICROBIOME STARTUPS IN FRANCE
    • TABLE 115 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 116 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 118 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing use of microbiome services in clinical research to drive growth
    • TABLE 119 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 120 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 122 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing prevalence of chronic diseases to drive market
    • TABLE 123 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 124 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 126 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 127 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 128 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 129 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 130 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 EUROPE: IMPACT OF RECESSION
  • 10.4 ASIA PACIFIC
    • FIGURE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT
    • TABLE 131 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Increasing investments in R&D to drive growth
    • TABLE 136 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 137 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 138 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 139 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Significant growth in geriatric population to present opportunities for market growth
    • TABLE 140 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 141 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 143 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing prevalence of chronic diseases to support growth
    • TABLE 144 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 145 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 147 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 148 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 151 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 ASIA PACIFIC: IMPACT OF RECESSION
  • 10.5 LATIN AMERICA
    • TABLE 152 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 153 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 154 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 156 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Growing adoption of next-generation sequencing technologies to propel growth
    • TABLE 157 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 158 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 159 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 160 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 REST OF LATIN AMERICA
    • TABLE 161 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 162 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 163 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 164 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 LATIN AMERICA: IMPACT OF RECESSION
  • 10.6 MIDDLE EAST & AFRICA
    • TABLE 165 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 166 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 167 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 168 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.6.1 MIDDLE EAST & AFRICA: IMPACT OF RECESSION

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 28 STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020-2023
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 29 MICROBIOME SEQUENCING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • TABLE 169 MICROBIOME SEQUENCING SERVICES MARKET: DEGREE OF COMPETITION
  • 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020-2022
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 31 MICROBIOME SEQUENCING SERVICES MARKET: COMPANY EVALUATION QUADRANT, 2022
  • 11.6 COMPETITIVE SCENARIO
    • TABLE 170 SERVICE LAUNCHES
    • TABLE 171 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 CHARLES RIVER LABORATORIES
    • TABLE 172 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
    • 12.1.2 EUROFINS SCIENTIFIC
    • TABLE 173 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 12.1.3 BGI GROUP
    • TABLE 174 BGI GROUP: BUSINESS OVERVIEW
    • 12.1.4 COSMOSID
    • TABLE 175 COSMOSID: BUSINESS OVERVIEW
    • 12.1.5 MICROBA
    • TABLE 176 MICROBA: BUSINESS OVERVIEW
    • 12.1.6 QIAGEN N.V.
    • TABLE 177 QIAGEN N.V.: BUSINESS OVERVIEW
    • FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
    • 12.1.7 MICROBIOME INSIGHTS
    • TABLE 178 MICROBIOME INSIGHTS: BUSINESS OVERVIEW
    • 12.1.8 BASECLEAR
    • TABLE 179 BASECLEAR: BUSINESS OVERVIEW
    • 12.1.9 CD GENOMICS
    • TABLE 180 CD GENOMICS: COMPANY OVERVIEW
    • 12.1.10 ZYMO RESEARCH CORPORATION
    • TABLE 181 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
    • 12.1.11 ORASURE TECHNOLOGIES
    • TABLE 182 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 35 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2022)
    • 12.1.12 MR DNA
    • TABLE 183 MR DNA: BUSINESS OVERVIEW
    • 12.1.13 EREMID GENOMIC SERVICES
    • TABLE 184 EREMID GENOMIC SERVICES: BUSINESS OVERVIEW
    • 12.1.14 CLINICAL-MICROBIOMICS A/S
    • TABLE 185 CLINICAL-MICROBIOMICS A/S: BUSINESS OVERVIEW
    • 12.1.15 NOVOGENE CO., LTD.
    • TABLE 186 NOVOGENE CO., LTD.: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 EZBIOME
    • 12.2.2 BOSTER BIOLOGICAL TECHNOLOGY
    • 12.2.3 ZIFO
    • 12.2.4 OMICS2VIEW.CONSULTING GBR
    • 12.2.5 MACROGEN, INC.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS